203 related articles for article (PubMed ID: 9193326)
21. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients.
Sixel KE; Aznar MC; Ung YC
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):199-204. PubMed ID: 11163515
[TBL] [Abstract][Full Text] [Related]
22. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume.
Borger JH; Hooning MJ; Boersma LJ; Snijders-Keilholz A; Aleman BM; Lintzen E; van Brussel S; van der Toorn PP; Alwhouhayb M; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1131-8. PubMed ID: 17606332
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison of conventional and forward-planned intensity-modulated techniques for comprehensive locoregional irradiation of post-mastectomy left breast cancers.
Cavey ML; Bayouth JE; Endres EJ; Pena JM; Colman M; Hatch S
Med Dosim; 2005; 30(2):107-16. PubMed ID: 15922178
[TBL] [Abstract][Full Text] [Related]
24. Reducing cardiac dose in post-operative irradiation of breast cancer patients: the relative importance of patient positioning and CT scan planning.
Canney PA; Deehan C; Glegg M; Dickson J
Br J Radiol; 1999 Oct; 72(862):986-93. PubMed ID: 10673950
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients.
Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785
[TBL] [Abstract][Full Text] [Related]
26. Analysis of cardiac and pulmonary complication probabilities after radiation therapy for patients with early-stage breast cancer.
Utehina O; Popovs S; Purina D; Slosberga I; Vevere I; Emzins D; Berzins J; Valuckas KP; Janulionis E; Miller A
Medicina (Kaunas); 2009; 45(4):276-85. PubMed ID: 19423958
[TBL] [Abstract][Full Text] [Related]
27. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer.
Tan W; Liu D; Xue C; Xu J; Li B; Chen Z; Hu D; Wang X
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1689-97. PubMed ID: 21621342
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer.
Correa CR; Litt HI; Hwang WT; Ferrari VA; Solin LJ; Harris EE
J Clin Oncol; 2007 Jul; 25(21):3031-7. PubMed ID: 17634481
[TBL] [Abstract][Full Text] [Related]
29. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.
Appelt AL; Vogelius IR; Bentzen SM
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):147-52. PubMed ID: 22910644
[TBL] [Abstract][Full Text] [Related]
30. Impact of post-operative radiation on coronary arteries in patients of early breast cancer: A pilot dosimetric study from a tertiary cancer care center from India.
Roy S; Mondal D; Melgandi W; Jana M; Chowdhury KK; Das S; Haresh KP; Gupta S; Sharma D; Julka PK; Rath GK
Indian J Cancer; 2015; 52(1):114-7. PubMed ID: 26837996
[TBL] [Abstract][Full Text] [Related]
31. Tomotherapy and multifield intensity-modulated radiotherapy planning reduce cardiac doses in left-sided breast cancer patients with unfavorable cardiac anatomy.
Coon AB; Dickler A; Kirk MC; Liao Y; Shah AP; Strauss JB; Chen S; Turian J; Griem KL
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):104-10. PubMed ID: 20004529
[TBL] [Abstract][Full Text] [Related]
32. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment.
Harris EE; Correa C; Hwang WT; Liao J; Litt HI; Ferrari VA; Solin LJ
J Clin Oncol; 2006 Sep; 24(25):4100-6. PubMed ID: 16908933
[TBL] [Abstract][Full Text] [Related]
33. The use of computed tomography in radiotherapy treatment planning for breast cancer. How does conventional radiotherapy planning compare with virtual?
Bauduceau O; Bollet MA; Pons P; Kirova YM; Fayolle M; Zervoudis S; Campana F
J BUON; 2008; 13(2):245-51. PubMed ID: 18555473
[TBL] [Abstract][Full Text] [Related]
34. Clinical experience in breast irradiation with intensity modulated photon beams.
Cozzi L; Fogliata A; Nicolini G; Bernier J
Acta Oncol; 2005; 44(5):467-74. PubMed ID: 16118080
[TBL] [Abstract][Full Text] [Related]
35. Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation.
van der Laan HP; Korevaar EW; Dolsma WV; Maduro JH; Langendijk JA
Radiother Oncol; 2010 Feb; 94(2):235-40. PubMed ID: 20080312
[TBL] [Abstract][Full Text] [Related]
36. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer.
Gyenes G; Rutqvist LE; Liedberg A; Fornander T
Radiother Oncol; 1998 Aug; 48(2):185-90. PubMed ID: 9783890
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive analysis of cardiac dose in balloon-based high-dose-rate brachytherapy for left-sided breast cancer.
Valakh V; Kim Y; Werts ED; Trombetta MG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1698-705. PubMed ID: 21601371
[TBL] [Abstract][Full Text] [Related]
38. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer.
D'Errico MP; Grimaldi L; Petruzzelli MF; Gianicolo EA; Tramacere F; Monetti A; Placella R; Pili G; Andreassi MG; Sicari R; Picano E; Portaluri M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e239-46. PubMed ID: 21640499
[TBL] [Abstract][Full Text] [Related]
39. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.
Flejmer AM; Edvardsson A; Dohlmar F; Josefsson D; Nilsson M; Witt Nyström P; Dasu A
Acta Oncol; 2016 May; 55(5):577-83. PubMed ID: 27027913
[TBL] [Abstract][Full Text] [Related]
40. Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk.
Hjelstuen MH; Mjaaland I; Vikström J; Dybvik KI
Acta Oncol; 2012 Mar; 51(3):333-44. PubMed ID: 22171587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
